Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 377

1.

Analysis of alpha-methylacyl-CoA racemase (P504S) expression in high-grade prostatic intraepithelial neoplasia.

Wu CL, Yang XJ, Tretiakova M, Patton KT, Halpern EF, Woda BA, Young RH, Jiang Z.

Hum Pathol. 2004 Aug;35(8):1008-13.

PMID:
15297968
2.
3.
6.

Prospective evaluation of AMACR (P504S) and basal cell markers in the assessment of routine prostate needle biopsy specimens.

Browne TJ, Hirsch MS, Brodsky G, Welch WR, Loda MF, Rubin MA.

Hum Pathol. 2004 Dec;35(12):1462-8.

PMID:
15619204
7.

Detection of alpha-methylacyl-coenzyme A racemase in postradiation prostatic adenocarcinoma.

Yang XJ, Laven B, Tretiakova M, Blute RD Jr, Woda BA, Steinberg GD, Jiang Z.

Urology. 2003 Aug;62(2):282-6.

PMID:
12893336
8.

Human telomerase and alpha-methylacyl-coenzyme A racemase in prostatic carcinoma. A comparative immunohistochemical study.

Puebla-Mora AG, Heras A, Cano-Valdez AM, Domínguez-Malagón H.

Ann Diagn Pathol. 2006 Aug;10(4):205-8.

PMID:
16844561
9.

Alpha-methylacyl-CoA racemase (AMACR) in fine-needle aspiration specimens of prostate lesions.

Kaić G, Tomasović-Loncarić C.

Diagn Cytopathol. 2009 Nov;37(11):803-8. doi: 10.1002/dc.21103.

PMID:
19459159
10.

P504S/alpha-methylacyl-CoA racemase: a useful marker for diagnosis of small foci of prostatic carcinoma on needle biopsy.

Jiang Z, Wu CL, Woda BA, Dresser K, Xu J, Fanger GR, Yang XJ.

Am J Surg Pathol. 2002 Sep;26(9):1169-74.

PMID:
12218573
11.

Prognostic significance of alpha-methylacyl-coA racemase among men with high grade prostatic intraepithelial neoplasia in prostate biopsies.

Stewart J, Fleshner N, Cole H, Toi A, Sweet J.

J Urol. 2008 May;179(5):1751-5; discussion 1755. doi: 10.1016/j.juro.2008.01.012. Epub 2008 Mar 17.

PMID:
18343427
12.

Diagnostic utility of alpha-methylacyl CoA racemase (P504S) on prostate needle biopsy.

Jiang Z, Woda BA.

Adv Anat Pathol. 2004 Nov;11(6):316-21. Review.

PMID:
15505533
13.

Alpha-methylacyl-CoA racemase (P504S)/34betaE12/p63 triple cocktail stain in prostatic adenocarcinoma after hormonal therapy.

Sung MT, Jiang Z, Montironi R, MacLennan GT, Mazzucchelli R, Cheng L.

Hum Pathol. 2007 Feb;38(2):332-41. Epub 2006 Nov 28.

PMID:
17134736
14.

Comparison of annexin II, p63 and alpha-methylacyl-CoA racemase immunoreactivity in prostatic tissue: a tissue microarray study.

Stewart J, Fleshner N, Cole H, Sweet J.

J Clin Pathol. 2007 Jul;60(7):773-80. Epub 2006 Aug 17.

15.

Expression of alpha-Methylacyl-CoA racemase (P504S) in atypical adenomatous hyperplasia of the prostate.

Yang XJ, Wu CL, Woda BA, Dresser K, Tretiakova M, Fanger GR, Jiang Z.

Am J Surg Pathol. 2002 Jul;26(7):921-5.

PMID:
12131160
17.

Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer.

Luo J, Zha S, Gage WR, Dunn TA, Hicks JL, Bennett CJ, Ewing CM, Platz EA, Ferdinandusse S, Wanders RJ, Trent JM, Isaacs WB, De Marzo AM.

Cancer Res. 2002 Apr 15;62(8):2220-6.

18.

Kinetic fluorescence reverse transcriptase-polymerase chain reaction for alpha-methylacyl CoA racemase distinguishes prostate cancer from benign lesions.

Schostak M, Miller K, Krause H, Schrader M, Kempkensteffen C, Kollermann J.

Cancer Detect Prev. 2006;30(5):449-54. Epub 2006 Oct 25.

PMID:
17067752
19.

[Detection of P504S (alpha-methylacyl-CoA racemase) in prostatic adenocarcinomas].

Xiao Y, Chen J, Luo YF, Cao JL, Ling Q, Jin F.

Zhonghua Yi Xue Za Zhi. 2004 Aug 17;84(16):1362-6. Chinese.

PMID:
15387946
20.

Alpha methylacyl-CoA racemase (AMACR) in prostate adenocarcinomas from Japanese patients: is AMACR a "race"-dependent marker?

Yamada H, Tsuzuki T, Maeda N, Yamauchi Y, Yoshida S, Ishida R, Nishikimi T, Yokoi K, Kobayashi H.

Prostate. 2013 Jan;73(1):54-9. doi: 10.1002/pros.22539. Epub 2012 May 16.

PMID:
22593005

Supplemental Content

Support Center